These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8361646)

  • 1. CSF and serum metabolic profile of patients with Huntington's chorea: a study by high resolution proton NMR spectroscopy and HPLC.
    Nicoli F; Vion-Dury J; Maloteaux JM; Delwaide C; Confort-Gouny S; Sciaky M; Cozzone PJ
    Neurosci Lett; 1993 May; 154(1-2):47-51. PubMed ID: 8361646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease.
    Verwaest KA; Vu TN; Laukens K; Clemens LE; Nguyen HP; Van Gasse B; Martins JC; Van Der Linden A; Dommisse R
    Biochim Biophys Acta; 2011 Nov; 1812(11):1371-9. PubMed ID: 21867751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Free aminoacids concentration in the plasma, red cell hemolysates and cerebrospinal fluid of patients with Huntington's chorea (author's transl)].
    Bień A; Stepniewska E; Stepniewski M; Szafran Z
    Przegl Lek; 1975; 32(11):796-802. PubMed ID: 129792
    [No Abstract]   [Full Text] [Related]  

  • 4. [On changes in the composition of cerebrospinal fluid in the choreatic syndrome].
    Bruck J; Gerstenbrand F; Gnad H; Gründig E; Prosenz P
    J Neurol Sci; 1967; 5(2):257-65. PubMed ID: 4228547
    [No Abstract]   [Full Text] [Related]  

  • 5. What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies.
    Perry TL; Hansen S
    Neurology; 1990 Jan; 40(1):20-4. PubMed ID: 1967491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Familial amyotrophic lateral sclerosis associated with Huntington chorea with increased aspartate level in the cerebrospinal fluid].
    Blin O; Samuel D; Guieu R; Pouget J; Nieoullon A; Serratrice G
    Rev Neurol (Paris); 1992; 148(2):144-6. PubMed ID: 1534926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
    Perry TL; Hansen S; Wall RA; Gauthier SG
    J Neurochem; 1982 Mar; 38(3):766-73. PubMed ID: 6460090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's disease - imbalance of free amino acids in the cerebrospinal fluid of patients and offspring at-risk.
    Oepen G; Cramer H; Bernasconi R; Martin P
    Arch Psychiatr Nervenkr (1970); 1982; 231(2):131-40. PubMed ID: 6461312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma-aminoacid levels in Huntington's chorea.
    Perry TL; Diamond S; Hansen S; Stedman D
    Lancet; 1969 Apr; 1(7599):806-8. PubMed ID: 4180363
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot study.
    McGarry A; Gaughan J; Hackmyer C; Lovett J; Khadeer M; Shaikh H; Pradhan B; Ferraro TN; Wainer IW; Moaddel R
    Sci Rep; 2020 Nov; 10(1):20490. PubMed ID: 33235276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.
    Rodrigues FB; Byrne LM; Lowe AJ; Tortelli R; Heins M; Flik G; Johnson EB; De Vita E; Scahill RI; Giorgini F; Wild EJ
    J Neurochem; 2021 Jul; 158(2):539-553. PubMed ID: 33797782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA].
    Simanyi M; Gerstenbrand F; Gründig E; Schedl R; Weiss H
    Z Neurol; 1973 Mar; 204(1):67-80. PubMed ID: 4121504
    [No Abstract]   [Full Text] [Related]  

  • 14. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
    Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
    Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease.
    Heyes MP; Swartz KJ; Markey SP; Beal MF
    Neurosci Lett; 1991 Jan; 122(2):265-9. PubMed ID: 1827518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum and csf proteins in Huntington's chorea].
    Dzudza M; Dzudza D
    Med Arh; 1974; 28(3):313-8. PubMed ID: 4283375
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased plasma alanine and isoleucine in Huntington's disease.
    Reilmann R; Rolf LH; Lange HW
    Acta Neurol Scand; 1995 Mar; 91(3):222-4. PubMed ID: 7793240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington chorea, but not Parkinson disease.
    Gårseth M; Sonnewald U; White LR; Rød M; Zwart JA; Nygaard O; Aasly J
    J Neurosci Res; 2000 Jun; 60(6):779-82. PubMed ID: 10861790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission.
    Garrett MC; Soares-da-Silva P
    J Neurochem; 1992 Jan; 58(1):101-6. PubMed ID: 1309230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy.
    Tsang TM; Woodman B; McLoughlin GA; Griffin JL; Tabrizi SJ; Bates GP; Holmes E
    J Proteome Res; 2006 Mar; 5(3):483-92. PubMed ID: 16512662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.